The DOI matches its Crossref record.
Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency
Abstract
Summary: We investigated the presence of the gene mutation of factor V, FV R506Q or factor V Leiden, responsible for activated protein C resistance, in DNA samples of 127 probands and 188 relatives from 128 families with antithrombin deficiency. The factor V mutation was identified in 18 families. Nine families were available to assess the mode of inheritance and the clinical relevance of combined defects. The factor V and antithrombin genes both map to chromosome 1. Segregation of the defects on opposite chromosomes was observed in three families. Co-segregation with both defects on the same chromosome was demonstrated in four families. In one family a de novo mutation of the antithrombin gene and in another a crossing-over event were the most likely explanations for the observed inheritance patterns. In six families with type I or II antithrombin deficiency (reactive site or pleiotropic effect), 11 of the 12 individuals with both antithrombin deficiency and the factor V mutation developed thrombosis. The median age of their first thrombotic episode was 16 years (range 0-19); this is low compared with a median age of onset of 26 years (range 20-49) in 15 of 30 carriers with only a defect in the antithrombin gene. One of five subjects with only factor V mutation experienced thrombosis at 40 years of age. In three families with type II heparin binding site deficiencies, two of six subjects with combined defects experienced thrombosis; one was homozygous for the heparin binding defect. Our results show that, when thrombosis occurs at a young age in antithrombin deficiency, the factor V mutation is a likely additional risk factor. Co-segregation of mutations in the antithrombin and factor V genes provides a molecular explanation for severe thrombosis in several generations. The findings support that combinations of genetic risk factors underly differences in thrombotic risk in families with thrombophilia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Venous thrombosis: a multicausal disease
Rosendaal, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10266-0 · Cited by 1,576
Self-citationCooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 645
Inherited Thrombophilia: Part 1
Lane, D. A., Mannucci, P. M., Bauer, K. A., Bertina, R. M., Bochkov, N. P., Boulyjnkov, V., Chandy, M., Dahlback, B., Ginter, E. K., Miletich, J. P., et al. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650638 · Cited by 581
Self-citationThe Epidemiology of Venous Thromboembolism in the Community
Mohr, D., Petterson, T., Lohse, C., O’Fallon, W. M., Melton, L. J., Heit, J., & Silverstein, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616243 · Cited by 571
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
Self-citation
Metadata
- Authors
- van Boven, H. H., Reitsma, P. H., Rosendaal, F. R., Bayston, T. A., Chowdhury, V, Borg, J.-Y., Bauer, K. A., Scharrer, I., Conard, J., & Lane, D. A.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1996
- Volume
- 75
- Issue
- 03
- Pages
- 417-421
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2399373446
- Cited by
- 230
- References
- 0
- FWCI
- 18.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency. https://app.cochat.ai/papers/10.1055/s-0038-1650289
- The paper
- van Boven, H. H., Reitsma, P. H., Rosendaal, F. R., Bayston, T. A., Chowdhury, V, Borg, J.-Y., Bauer, K. A., Scharrer, I., Conard, J., & Lane, D. A. (1996). Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0038-1650289
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.